首个对称二甲基精氨酸(SDMA)全自动免疫检测及参考区间建立
本研究评估首个全自动SDMA免疫检测,并与金标准液相色谱-串联质谱(LC-MS/MS)比较性能,同时利用诊断与实验室医学协会样本库中超过五百份样本建立参考区间。结果显示该自动化免疫检测可提供快速、准确、可靠的SDMA测量,有望将SDMA引入临床辅助肾脏功能异常的诊治。
要点
- SDMA对肌肉量等肾外因素不敏感,是评估肾功能的潜力标志物。
- 首个全自动SDMA免疫检测与LC-MS/MS比较显示性能良好。
- 利用超过五百份样本建立了SDMA参考区间。
核心结论
- 全自动IDEXX SDMA®免疫检测可提供快速、准确、可靠的SDMA测量。
- 该检测有望将SDMA引入临床,辅助肾脏功能异常的诊断与治疗。
研究设计与样本
- 研究评估首个全自动SDMA免疫检测,并与金标准LC-MS/MS方法比较性能。
- 使用诊断与实验室医学协会(原AACC)样本库中超过五百份样本建立参考区间。
主要发现
- 自动化SDMA免疫检测提供快速、准确、可靠的测量结果。
临床怎么用
- 该自动化SDMA检测有望用于临床辅助诊断和治疗肾脏功能障碍。
局限性
- 摘要未报告自动化免疫检测与LC-MS/MS比较的具体性能数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The measurement of kidney function is critical for early detection and management of acute kidney injury and chronic kidney disease. Traditional biomarkers such as creatinine and cystatin C are commonly used but have significant limitations due to factors such as muscle mass, diet, hydration, and extrarenal conditions. Creatinine-based equations have raised concerns over health equity regarding racial differences in estimates of kidney function. In response, symmetric dimethylarginine (SDMA) has emerged as a promising biomarker due to its reduced sensitivity to muscle mass and other extrarenal variables. However, the clinical adoption of SDMA has been limited by the need for more efficient, automated testing methods. This study aimed to evaluate the first fully automated immunoassay for SDMA and compare its performance to the gold-standard liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. We also established reference intervals using over five hundred samples from the Association for Diagnostics and Laboratory Medicine (formerly AACC) sample bank. Our results demonstrate that the automated IDEXX SDMA® immunoassay provides rapid, accurate, and reliable measurements, offering significant potential to introduce this biomarker to the clinical space to aid in diagnosing and treating kidney dysfunction.
引用
- Kodger J, Strong-Townsend M, Farace G, et al. First automated immunoassay for symmetric dimethylarginine (SDMA) with reference interval establishment. Clin Chim Acta. 2025. PMID: 41038365. doi:10.1016/j.cca.2025.120638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。